Neuriva, a leading brain supplement and an Amazon best seller, was raced to market in only 12 months, plaintiffs David Williams and Caroll Anglade say in a suit filed Wednesday in the U.S. District Court for the Southern District of Florida.
The companies have no scientific or clinical proof that Neuriva provides any benefit to the brain or that its key ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.